Spruce Biosciences, Inc. (NASDAQ:SPRB) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Spruce Biosciences Investor Call [Operator Instructions]. Please note, this conference call is being recorded.
Spruce Biosciences Inc. (SPRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 2,609,125 | $756,907 | 0.04% | |
| 2. | Ikarian Capital Neil Shahrestani | 1,000,000 | $290,100 | 0.04% | |
| 3. | ADAR1 Capital Management Daniel Schneeberger | 403,716 | $117,118 | 0.02% | |
| 4. | Renaissance Technologies Jim Simons | 382,900 | $111,079 | -6% | 0% |
| 5. | Lion Point Didric Cederholm | 75,000 | $21,758 | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.17 | 630,400 | $1,998,368.00 | 1,326,305 | 2023-02-16 | Filing | |
| $3.17 | 2,208,000 | $6,999,360.00 | 6,722,336 | 2023-02-16 | Filing | |
| $15.00 | 250,000 | $3,750,000.00 | 4,989,336 | 2020-10-14 | Filing | |
| $15.00 | 250,000 | $3,750,000.00 | 2,148,281 | 2020-10-14 | Filing | |
| $15.00 | 200,000 | $3,000,000.00 | 1,792,518 | 2020-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.75 | 465,021 | $350,951.35 | 2,550,000 | 2024-03-21 | Filing | |
| $0.73 | 359,979 | $264,080.59 | 3,015,021 | 2024-03-20 | Filing | |
| $0.76 | 593,000 | $447,715.00 | 3,375,000 | 2024-03-19 | Filing | |
| $0.77 | 842,020 | $647,008.17 | 3,968,000 | 2024-03-18 | Filing | |
| $0.89 | 1,912,316 | $1,698,901.53 | 4,810,020 | 2024-03-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,896,518 | $840,280 | 0.02% | |
| 2. | 843,844 | $244,715 | 0% | |
| 3. | 288,800 | $83,781 | 0% | |
| 4. | 276,708 | $80,289 | 0% | |
| 5. | 124,734 | $36,185 | 0% |
News See All
5 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.
Hedge Fund and Insider Trading News: Marc Lasry, Standard General, Third Point LLC, Irenic Capital Management, Millennium Management, Soroban Capital Partners, Point72 Asset Management, Vishay Precision Group Inc (VPG), Spruce Biosciences Inc (SPRB), and More
Billionaire investor Marc Lasry has reached a deal to sell his stake in the Milwaukee Bucks to Jimmy and Dee Haslam, owners of the National Football League’s Cleveland Browns, according to a person ...
Spruce Biosciences, Inc. (SPRB): Are Hedge Funds Right About This Stock?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
5 Best Healthcare Stocks Under $20 According to Michael Castor's Sio Capital
In this article, we discuss the 5 best healthcare stocks under $20 according to Michael Castor's Sio Capital.